603718.SH
*ST海利
SSE · Healthcare · Biotechnology · CN
CNY 2.93
−2.01%Year over year
Reported trailing growth
- Revenue
- -33.9%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +71.8%
- Operating cash flow
- +61.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -14.4%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -44.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026